183 related articles for article (PubMed ID: 8064302)
1. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
Ichimiya A; Herholz K; Mielke R; Kessler J; Slansky I; Heiss WD
J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302
[TBL] [Abstract][Full Text] [Related]
2. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
[TBL] [Abstract][Full Text] [Related]
5. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
6. FDG PET and differential diagnosis of dementia.
Herholz K
Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
[TBL] [Abstract][Full Text] [Related]
7. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
Friedland RP; Budinger TF; Ganz E; Yano Y; Mathis CA; Koss B; Ober BA; Huesman RH; Derenzo SE
J Comput Assist Tomogr; 1983 Aug; 7(4):590-8. PubMed ID: 6602819
[TBL] [Abstract][Full Text] [Related]
8. High-resolution PET studies in Alzheimer's disease.
Kumar A; Schapiro MB; Grady C; Haxby JV; Wagner E; Salerno JA; Friedland RP; Rapoport SI
Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
[TBL] [Abstract][Full Text] [Related]
9. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
Koss E; Friedland RP; Ober BA; Jagust WJ
Am J Psychiatry; 1985 May; 142(5):638-40. PubMed ID: 3872604
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
11. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography.
Alavi A; Reivich M; Ferris S; Christman D; Fowler J; MacGregor R; Farkas T; Greenberg J; Dann R; Wolf A
Exp Brain Res; 1982; Suppl 5():187-95. PubMed ID: 6983979
[No Abstract] [Full Text] [Related]
12. [Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography].
Sakamoto S
Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):222-34. PubMed ID: 2376611
[TBL] [Abstract][Full Text] [Related]
13. [Cerebral glucose metabolism in dementia (PET-FDG study)].
Hatazawa J; Itoh M; Matsuzawa T
Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
[TBL] [Abstract][Full Text] [Related]
14. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
15. Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset.
Small GW; Kuhl DE; Riege WH; Fujikawa DG; Ashford JW; Metter EJ; Mazziotta JC
Arch Gen Psychiatry; 1989 Jun; 46(6):527-32. PubMed ID: 2730277
[TBL] [Abstract][Full Text] [Related]
16. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
17. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
19. Patterns of cortical activity and memory performance in Alzheimer's disease.
Schröder J; Buchsbaum MS; Shihabuddin L; Tang C; Wei TC; Spiegel-Cohen J; Hazlett EA; Abel L; Luu-Hsia C; Ciaravolo TM; Marin D; Davis KL
Biol Psychiatry; 2001 Mar; 49(5):426-36. PubMed ID: 11274654
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
